GTR 88100015

Bids Are Invited For Price Registration For The Eventual Acquisition Of Medication And Hospital Medical Supplies To Meet The Needs Of The Hmapa Oncology Service.

ICB — International Competitive Bid Closed South America
Tender Information
GTR Reference
88100015
Tendering Authority
Subscribe to view
Tender No
90029/2024
Financer Name
Self-Funded
Work Title
Bids Are Invited For Price Registration For The Eventual Acquisition Of Medication And Hospital Medical Supplies To Meet The Needs Of The Hmapa Oncology Service.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
18-11-2024 Closed
Work Detail
Price Registration For The Eventual Acquisition Of Medication And Hospital Medical Supplies To Meet The Needs Of The Hmapa Oncology Service.. Cytarabine,Cytarabine,Dacarbazine,Dacarbazine,Docetaxel,Docetaxel,Gemcitabine Hydrochloride,Gemcitabine Hydrochloride,Idarubicin Hydrochloride,Idarubicin Hydrochloride,Ifosfamide,Ifosfamide,Irinotecan Hydrochloride,Irinotecan Hydrochloride,Oxaliplatin,Oxaliplatin,Pemetrexed,Pemetrexed,Temozolomide,Temozolomide,Temozolomide,Tempozolomide,Rituximab,Rituximab,Abatacept,Abatacept,Abiraterone Acetate,Zoledronic Acid,Zoledronic Acid,Afatinib Dimaleate,Afatinib Dimaleate,Alectinib,Amivantamab,Anagrelide Hydrochloride,Anastrozole,Apalutamide,Atezolizumab,Atezolizumab,Avelumab,Axitinib,Axitinib,Azacitidine,Bendamustine,Bendamustine,Bevacizumab,Bevacizumab,Bicalutamide,Bortezomib,Bleomycin Sulfate,Brentuximab Vedotin,Brigatinib,Brigatinib,Brigatinib,Cabazitaxel,Cabozantinib,Cabozantinib,Cabozantinib,Capecitabine,Capecitabine,Alpelisib,Alpelisib,Carboplatin,Cemiplimab,Cetuximab,Cetuximab,Cobimetinib Hemifumarate,Cyclophosphamide,Cyclophosphamide,Cimetidine,Cyproterone Acetate,Cisplatin,Cladribine,Chlorambucil,Crizotinib,Crizotinib,Dasatinib,Daratumumab,Darolutamide,Decitabine,Deferasirox,Deferasirox,Degarelix,Degarelix,Denosumab,Denosumab,Dexrazoxane,Diphenhydramine Hydrochloride,Dostarlimab,Doxorubicin Hydrochloride,Doxorubicin Hydrochloride,Durvalumab,Durvalumab,Obinutuzumab,Obinutuzumab,Elotuzumab,Elotuzumab,Enfortumab,Enfortumab,Enzalutamide,Epirubicin Hydrochloride
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
80c75314-12cc-48b2-9358-0b1a401ca7bb.html
Attachments
Additional Details Available on Click
  • Tendering Authority
  • Publication Document (Tender Document / Tender Notice)
Disclaimer

We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.

Tell us about your Product / Services,

We will Find Tenders for you

TenderDetail
Loading tenders